Axis HealthCare, Tulsa
US$ 22.70
tirzepatide approved in canada Zepbound for obesity and sleep apnea treatment π£ BIG NEWS IN OBESITY
Description
Dangerous symptoms include persistent severe dizziness with chest pain, fainting, vision loss, or confusionthese require emergency evaluation
These may include: Starting dosage Dosage increases over time Diet quality Protein intake Sleep quality Stress levels Physical activity Underlying health conditions A personalized treatment plan can help improve long-term success and make appetite regulation more manageable
But they had no risk of adverse events
This medication should not be used
